Back to Journals » Drug Design, Development and Therapy

Drug Design, Development and Therapy

ISSN: 1177-8881


Editor-in-Chief: Prof. Dr. Frank Boeckler

An international, peer-reviewed, open access journal that spans the spectrum of drug design and development through to clinical applications. The journal is characterized by the rapid reporting of application notes, reviews, original research and clinical studies in all therapeutic areas. Clinical outcomes, patient safety, and programs for the development and effective, safe, and sustained use of medicines will be a feature of the journal. 

This journal is a member of and subscribes to the principles of the Committee on Publication Ethics (COPE).

Latest articles:

- 5 records -

Safety and Effectiveness of a Biosimilar Recombinant Human Growth Hormone in Children Requiring Growth Hormone Treatment: Analysis of Final Data from PATRO Children, an International, Post-Marketing Surveillance Study

Loche S, Kanumakala S, Backeljauw P, Schwab KO, Lechuga-Sancho AM, Esmael A, Urosevic D, Boldea A, Zabransky M

Drug Design, Development and Therapy 2024, 18:667-684

Published Date: 2 March 2024

Exploration of the in vitro Antiviral Effects and the Active Components of Changyanning Tablets Against Enterovirus 71

Ge Q, Zhang Z, Cao Z, Wu D, Xu C, Yao J, Gao J, Feng Y

Drug Design, Development and Therapy 2024, 18:651-665

Published Date: 2 March 2024

Clinical Study of Flumazenil Antagonizing Remimazolam on Nausea and Vomiting After Gynecologic Day Surgery

Wei Y, Zhu M, Man Y, Xiao H, Dong G, Shi X, Ji F

Drug Design, Development and Therapy 2024, 18:631-638

Published Date: 4 March 2024


Read more articles